Cargando…
Risks of Aromatase Inhibitor-Related Cardiotoxicity in Patients with Breast Cancer in Asia
SIMPLE SUMMARY: In Asian breast cancer patients, whether the risks of major adverse cardio- and cerebrovascular events (MACCEs) are different between users of aromatase inhibitors (AIs) and selective estrogen receptor modulators (SERMs) remains uncertain. In this nationwide cohort study, the risks o...
Autores principales: | Chang, Wei-Ting, Chen, Po-Wei, Lin, Hui-Wen, Kuo, Yu-Hsuan, Lin, Sheng-Hsiang, Li, Yi-Heng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833815/ https://www.ncbi.nlm.nih.gov/pubmed/35158776 http://dx.doi.org/10.3390/cancers14030508 |
Ejemplares similares
-
Risks of trastuzumab‐related cardiotoxicity in breast cancer patients in Taiwan
por: Chang, Wei‐Ting, et al.
Publicado: (2021) -
Association of Statin Use With Cancer- and Noncancer-Associated Survival Among Patients With Breast Cancer in Asia
por: Chang, Wei-Ting, et al.
Publicado: (2023) -
A Polymorphism at the 3′-UTR Region of the Aromatase Gene Is Associated with the Efficacy of the Aromatase Inhibitor, Anastrozole, in Metastatic Breast Carcinoma
por: Liu, Lei, et al.
Publicado: (2013) -
Role of aromatase inhibitors in breast cancer
por: Carpenter, R, et al.
Publicado: (2005) -
The association between tyrosine kinase inhibitors and fatal arrhythmia in patients with non-small cell lung cancer in Taiwan
por: Chang, Wei-Ting, et al.
Publicado: (2023)